A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder.
- Published In:
- Psychoneuroendocrinology, 34(6), 917-23 (2009)
- Database ID:
- RPEP-01486
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-01486APA
Guastella, Adam J; Howard, Alexandra L; Dadds, Mark R; Mitchell, Philip; Carson, Dean S. (2009). A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder.. Psychoneuroendocrinology, 34(6), 917-23. https://doi.org/10.1016/j.psyneuen.2009.01.005
MLA
Guastella, Adam J, et al. "A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder.." Psychoneuroendocrinology, 2009. https://doi.org/10.1016/j.psyneuen.2009.01.005
RethinkPeptides
RethinkPeptides Research Database. "A randomized controlled trial of intranasal oxytocin as an a..." RPEP-01486. Retrieved from https://rethinkpeptides.com/research/guastella-2009-a-randomized-controlled-trial
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.